Johns Hopkins University School of Medicine, Baltimore, MD, USA.
J Allergy Clin Immunol. 2012 Nov;130(5):1078-84. doi: 10.1016/j.jaci.2012.07.058. Epub 2012 Sep 29.
The evaluation of asthma symptoms is a core outcome measure in asthma clinical research. The Asthma Symptom Utility Index (ASUI) was developed to assess the frequency and severity of asthma symptoms. The psychometric properties of the ASUI are not well characterized, and a minimal important difference (MID) is not established.
We assessed the reliability, validity, and responsiveness to change of the ASUI in a population of adult asthmatic patients. We also sought to determine the MID for the ASUI.
Adult asthmatic patients (n = 1648) from 2 previously completed multicenter randomized trials were included. Demographic information, spirometric results, ASUI scores, and other asthma questionnaire scores were obtained at baseline and during follow-up visits. Participants also kept a daily asthma diary.
The internal consistency reliability of the ASUI was 0.74 (Cronbach α). Test-retest reliability was 0.76 (intraclass correlation). Construct validity was demonstrated by significant correlations between ASUI scores and Asthma Control Questionnaire scores (Spearman correlation r = -0.79; 95% CI, -0.85 to -0.75; P < .001) and Mini Asthma Quality of Life Questionnaire scores (r = 0.59; 95% CI, 0.51-0.61; P < .001). Responsiveness to change was demonstrated, with significant differences between mean changes in ASUI scores across groups of participants differing by 10% in percent predicted FEV(1) (P < .001) and by 0.5 points in Asthma Control Questionnaire scores (P < .001). Anchor-based and statistical methods support an MID for the ASUI of 0.09 points.
The ASUI is reliable, valid, and responsive to changes in asthma control over time. The MID of the ASUI (range of scores, 0-1) is 0.09.
哮喘症状的评估是哮喘临床研究中的核心结局指标。哮喘症状效用指数(ASUI)是为评估哮喘症状的频率和严重程度而开发的。ASUI 的心理测量特性尚未得到很好的描述,也没有确定最小有意义差异(MID)。
我们评估了 ASUI 在成年哮喘患者人群中的可靠性、有效性和对变化的反应能力。我们还试图确定 ASUI 的 MID。
纳入了来自 2 项先前完成的多中心随机试验的成年哮喘患者(n=1648)。在基线和随访就诊时获得了人口统计学信息、肺量计结果、ASUI 评分和其他哮喘问卷评分。参与者还每天记录哮喘日记。
ASUI 的内部一致性可靠性为 0.74(Cronbach α)。测试-重测可靠性为 0.76(组内相关)。ASUI 评分与哮喘控制问卷评分(Spearman 相关 r=-0.79;95%CI,-0.85 至-0.75;P<.001)和 Mini 哮喘生活质量问卷评分(r=0.59;95%CI,0.51-0.61;P<.001)之间存在显著相关性,证明了结构效度。变化反应能力得到了证明,在预测 FEV1 百分比变化 10%的参与者组之间的 ASUI 评分均值变化之间存在显著差异(P<.001),在哮喘控制问卷评分上存在 0.5 分的差异(P<.001)。基于锚定和统计方法支持 ASUI 的 MID 为 0.09 分。
ASUI 具有可靠性、有效性和对哮喘控制随时间变化的反应能力。ASUI 的 MID(评分范围,0-1)为 0.09。